Fig. 3From: Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case reportUrodynamic study during treatment with oral propiverine. FDV first desire to void, NDV normal desire to void, MCC maximum cystometric capacityBack to article page